In STZ-treated rats, which present hyperglycemia and low insulin, autophagy proteins (LC3, ATG5, ATG12, and BECN1) were significantly elevated in the gastrocnemius muscle, which contributed to the increase of p-FOXO3a and the subsequent repression of mTOR. The gene discussed is MAP1LC3A; the disease is Hyperglycemia.